×
Choose Speciality

EXPLORE!

LOGIN

Recognizing Roxadustate-HIF-PH Inhibitor in CKD Anemia: Landmark Trials

  964 Views

Dr (Prof) NP Singh, Ghaziabad    29 November 2019

  • There are several new erythropoiesis-stimulating agents that may in the near future potentially improve the management of anemia.
  • The new agents will be administered less frequently with better stabilization of blood hemoglobin concentration.
  • There are also promising attempts to overcome the parenteral method of drug administration.
  • There is a real chance that the new compounds will be much more cost-effective than the currently-used epoietins.
  • This fact will certainly improve the management of anemia, the quality-of-life and hopefully also the survival of patients with chronic kideny disease.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.